The study showed that baseline NT-proBNP predicts combined cardiovascular mortality or HF hospitalisation at six months (hazard ratio [HR]: 2.12; 95% CI 1.06–4.22; p = 0.0328). This evidence concerns the gene NPPB and hydrops fetalis.